PRJNA503861
HIV fusion peptide vaccination study
Sequencing of longitudinally sampled B cells has provided unprecedented insight into antibody development. Here, in longitudinally sampled macaques, we compare vaccination regimens and track the development of five cross-clade neutralizing antibody lineages, each targeting the fusion peptide (FP) of HIV-1.